Table 3.
Variable | Class 1: Mostly ART with viral suppression n = 87 (53%, 95% CI 41–65%) |
Class 2: ART with viral suppression and condom use n = 46 (19%, 95% CI 16–41%) |
Class 3: ART with viral suppression and seroadaptive behaviour use n = 67 (18%, 95% CI 10–27%) |
---|---|---|---|
ART with viral suppression | 84% | 86% | 93% |
Consistent condom use | 0% | 100% | 15% |
Strategic positioning | 0% | 29% | 49% |
Serosorting and/or PrEP sorting: | |||
Both | 0% | 8% | 55% |
PrEP sorting only | 9% | 0% | 16% |
Serosorting only | 18% | 3% | 17% |
ART antiretroviral treatment, CI confidence interval, PrEP pre-exposure prophylaxis
RDS-II adjusted class sizes (%) and 95% confidence intervals are presented. RDS-II weights are inverse probability of sampling weights that are proportional to participant network size